Manav Wadhawan
Overview
Explore the profile of Manav Wadhawan including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
62
Citations
909
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Choudhury A, Kulkarni A, Arora V, Soin A, Dokmeci A, Chowdhury A, et al.
Hepatol Int
. 2025 Feb;
19(1):1-69.
PMID: 39961976
Acute-on-chronic liver failure (ACLF) is a condition associated with high mortality in the absence of liver transplantation. There have been various definitions proposed worldwide. The first consensus report of the...
2.
Ansari N, Wadhawan M
Best Pract Res Clin Gastroenterol
. 2024 Dec;
73:101963.
PMID: 39709217
Neurological complications in acute liver failure are the most common cause of mortality in this group of patients. Almost all neurologic complications arise from underlying increase in intracranial pressure in...
3.
Shriya A, Soni H, Sood G, Kumar N, Jamir I, Gupta A, et al.
J Clin Exp Hepatol
. 2024 Nov;
15(2):102422.
PMID: 39583914
Background/aims: Per-oral (PO) administration of tacrolimus (TAC) results in inadequate trough levels in the early postoperative period in liver-transplant (LT) recipients who undergo Roux-en-Y hepaticojejunostomy for biliary reconstruction. Sublingual administration...
4.
Prabhoo R, Pai U, Wadhwa A, Pillai B, Dsouza C, Wadhawan M, et al.
Euroasian J Hepatogastroenterol
. 2024 Jul;
14(1):99-119.
PMID: 39022200
How To Cite This Article: Prabhoo RY, Pai UA, Wadhwa A, . Multidisciplinary Consensus for Rationalizing the Use of Acid Suppressants in Children and Adults: CONFOR. Euroasian J Hepato-Gastroenterol 2024;14(1):99-119.
5.
Garg P, Madan K, Wali H, Wadhawan M, Acharya S, Bhargava R, et al.
Indian J Gastroenterol
. 2024 Jun;
PMID: 38869713
No abstract available.
6.
Maiwall R, Singh S, Angeli P, Moreau R, Krag A, Singh V, et al.
Hepatol Int
. 2024 Apr;
18(3):833-869.
PMID: 38578541
Acute-on-chronic liver failure (ACLF) is a syndrome that is characterized by the rapid development of organ failures predisposing these patients to a high risk of short-term early death. The main...
7.
Kumar A, Acharya S, Singh S, Duseja A, Madan K, Shukla A, et al.
J Clin Exp Hepatol
. 2023 Dec;
14(1):101269.
PMID: 38107186
Hepatocellular carcinoma (HCC) presents significant treatment challenges despite considerable advancements in its management. The Indian National Association for the Study of the Liver (INASL) first published its guidelines to aid...
8.
Ramaswamy A, Kulkarni A, John G, Rauthan A, Patil S, Duseja A, et al.
JCO Glob Oncol
. 2023 Nov;
9:e2300215.
PMID: 38033275
Purpose: Immune checkpoint inhibitors (ICIs) is the initial line of management in advanced hepatocellular carcinoma (HCC), but survivals in the real world are not known. Materials And Methods: A retrospective...
9.
Wadhawan M, Gupta C
J Clin Exp Hepatol
. 2023 Jul;
13(4):691-697.
PMID: 37440936
The liver is well known for its immunotolerance, but rejection without immunosuppression is frequently encountered post liver transplantation, especially in humans. Indeed, the amount of immunosuppression required post liver transplant...
10.
Reddy M, Mathur S, Sudhindran S, Gupta S, Rela M, Soin A, et al.
J Clin Exp Hepatol
. 2023 Mar;
13(2):303-318.
PMID: 36950486
Background: Deceased donor liver transplantation (DDLT) is increasing in India and now constitutes nearly one-third of all liver transplantation procedures performed in the country. There is currently no uniform national...